• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

    8.900 +0.250 (+2.89%)
    Streaming Delayed Price Updated: 3:57 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about CNS Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2
    ...
    14 15 16 17 18 19 20 21 Next >
    23 Stocks Moving in Thursday's Pre-Market Session
    Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday. Alterity Therapeutics Limited... 
    Via Benzinga
    50 Biggest Movers From Yesterday
    Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead... 
    Via Benzinga
    The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers Quoin Pharmaceuticals (NASDAQ: 
    Via Benzinga
    CNS Pharmaceuticals Announces Committee Approval of Pivotal Berubicin Study
    CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central... 
    Via Benzinga
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Switzerland Ethics Committee Approval of Pivotal Berubicin Study
    Via Investor Brand Network
    CNS Pharmaceuticals Announces Participation at Upcoming Virtual Investor Roundtable
    CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central... 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday! 
    Via InvestorPlace
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at Upcoming Virtual Investor Roundtable
    Via Investor Brand Network
    JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th
    - Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating... 
    From JTC Team, LLC
    Via AccessWire
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Berubicin’s Impressive Potential in Syndicated Broadcast
    Via Investor Brand Network
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Brickell Biotech (NASDAQ:BBI) shares moved upwards by 20.46% to $0.8 during Thursday's pre-market session. The company's market cap stands at $68.5 million... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current volume of 70.4 million shares is 943.37% of Progenity... 
    Via Benzinga
    The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
    Via Benzinga
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Doses First Group of Patients in Potentially Pivotal Trial
    Via Investor Brand Network
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers Xeris Pharmaceuticals (NASDAQ:XERS 
    Via Benzinga
    The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers Cellect Biotechnology (NASDAQ:APOP 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers Brickell Biotech (NASDAQ:BBI) stoc... 
    Via Benzinga
    Want to Buy CNS Pharmaceuticals (NASDAQ: CNSP) Stock? Read This First.
    CNS Pharmaceuticals (NASDAQ: CNSP) is a pre-clinical biotech company focusing on treatments for brain tumors. The firm holds the exclusive worldwide license for its main... 
    Via Benzinga
    FDA Grants Fast Track Designation to CNS Pharmaceuticals for Berubicin for the Treatment of Recurrent Glioblastoma Multiforme
    Via FinancialNewsMedia
    Global Brain Tumor Diagnosis & Treatment Market Could Exceed $880 Million By 2027
    Via FinancialNewsMedia
    CNS Pharmaceuticals Begins Enrollment, Screening Brain Cancer Study With Berubicin
    CNS Pharmaceuticals Inc (NASDAQ: CNSP) has opened enrollment for its Phase 2 study evaluating its lead candidate, Berubicin, for recurrent Glioblastoma... 
    Via Benzinga
    CNS Pharmaceuticals Commences Patient Enrollment in Potentially Pivotal Study of Berubicin
    CNS Pharmaceuticals today announced open enrollment for its potentially pivotal study evaluating the efficacy and safety of Berubicin in the treatment of recurrent GBM. 
    Via Talk Markets
    Global Glioblastoma Multiforme (GBM) Treatment Market Could Reach Nearly $1.8 Billion By 2027
    Via FinancialNewsMedia
    < Previous 1 2
    ...
    14 15 16 17 18 19 20 21 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.